Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2026-01-14 @ 11:21 AM
Study NCT ID:
NCT01008150
Status:
COMPLETED
Last Update Posted:
2021-10-25
First Post:
2009-11-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
Sponsor:
NSABP Foundation Inc
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
NSABP FB-7
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |